Company news

BELLUS Health Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

BELLUS Health announces appointment of Martin Tolar, m.d., ph.d. to its board of directors

October 6, 2010

Health Canada grants VIVIMIND¿ a natural health product number

September 30, 2010

Bellus Health reports results for second quarter ended June 30, 2010

August 9, 2010

BELLUS Health Inc.

May 12, 2010

Annual Meeting of Shareholders - BELLUS Health provides update on corporate and product developments

May 12, 2010

BELLUS Health reports results for first quarter ended March 31, 2010

May 12, 2010

BELLUS Health Inc. Annual and Special Meeting of Shareholders May 12, 2010

May 12, 2010

BELLUS Health Inc. Annual and Special Meeting of Shareholders May 12, 2010

May 11, 2010

BELLUS Health ends NC-503 diabetes development program following results

May 4, 2010

BELLUS Health and Celtic Therapeutics enter agreement for BELLUS' drug candidate KIACTA(TM)

April 29, 2010

BELLUS Health announces launch of NRM8499 Phase I clinical study for the treatment of Alzheimer's disease

April 1, 2010

BELLUS Health reports results for fourth quarter and year ended December 31, 2009

February 24, 2010

Roberto Bellini appointed President and CEO of BELLUS Health - Francesco Bellini to remain as Chairman of the Board; Charles Cavell appointed Deputy Chairman of the Board

December 15, 2009

BELLUS Health reports results for third quarter of fiscal 2009

November 10, 2009

TSX Delisting Review - BELLUS Health Inc. (BLU)

October 21, 2009

BELLUS Health announces results of rights offering

September 8, 2009

BayStreet.ca Research Alert: BELLUS Health Inc.

August 20, 2009

BELLUS Health reports results for first half of fiscal 2009

August 11, 2009

VIVIMIND(TM) granted certificate of free sale as food supplement in Italy - Premarket notification filed in the U.S.

July 16, 2009

BELLUS Health Inc. Announces Record Date for $12 Million Rights Offering To Common Shareholders

July 15, 2009

BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders

July 7, 2009

BELLUS Health Announces Exploratory Results in Peer-Reviewed Publication Reveal Tramiprosate Slows Atrophy of Brain Hippocampus with Preliminary Evidence of Beneficial Effect on Cognition

July 6, 2009

FMRC Family Trust completes reorganization of itsholdings of securities of Bellus Health Inc.

June 25, 2009

BELLUS Health Inc. Announces Officer

June 5, 2009

Annual General Meeting of Shareholders - BELLUS Health provides updates on corporate and financial developments

June 4, 2009

BELLUS Health Inc. Annual General Meeting of Shareholders June 4, 2009

June 2, 2009

BELLUS Health reports results for first quarter of fiscal 2009

May 6, 2009

BELLUS announces Chief Financial Officer to depart effective May 22, 2009

April 24, 2009

BELLUS Health inc. announces completion of first tranche of financing

April 16, 2009

Bellus Health Inc. provides an update on the financing and the restructuring of existing notes

April 8, 2009

BELLUS Health Inc. provides financing update and announces restructuring of existing notes

March 31, 2009

BELLUS Health provides financing update

March 24, 2009

BELLUS Health announces staff reductions to lower operating expenses

March 12, 2009

BELLUS Health reports results for the fourth quarter of 2008

February 26, 2009

BELLUS Health announces formal notice to voluntarily delist from NASDAQ

December 17, 2008

BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market

December 5, 2008

BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market

November 13, 2008

BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update

November 10, 2008

BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference

November 6, 2008

BELLUS Health provides update on activities

October 21, 2008

BELLUS Health Receives Nasdaq Deficiency Notice Relating to Market Value

October 15, 2008

VIVIMIND(TM), Canada's scientifically proven natural health product to protect memory function, is available starting today

September 2, 2008

Correction from source - BELLUS Health

August 12, 2008

BELLUS Health moves forward on nutraceutical and pharmaceutical fronts - Reports Results for First Half of 2008

August 5, 2008

BELLUS Health announces closing of Innodia acquisition

July 17, 2008

BELLUS Health signs agreement to acquire Innodia

July 16, 2008

BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference

May 15, 2008

BELLUS HEALTH reports results for first quarter of fiscal 2008

May 5, 2008

At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)

April 15, 2008

← Newer news releases

Decks